Environmental

XRAY’s R&D intensity is moderate versus medtech peers, supporting product stewardship and lower-material waste innovation, but it is not clearly best-in-class.

The company’s capital discipline appears acceptable, with low stock-based compensation relative to revenue versus many peers, limiting governance-linked sustainability concerns.

High leverage can constrain funding for environmental upgrades and compliance initiatives versus stronger-balance-sheet peers, increasing execution risk over a 2–5 year horizon.

No post-August 2025 filing evidence was provided on emissions, energy, or waste, so the environmental assessment relies mainly on capital-allocation proxies rather than direct operational disclosures.

Social

XRAY’s dental and medical-device exposure makes product safety and quality central, and its position appears broadly in line with regulated-device peers rather than leading.

Moderate R&D spend supports incremental product improvement and user safety, but the available metrics do not indicate a materially stronger social profile than peers.

Low stock-based compensation suggests less reliance on equity incentives than many peers, which can reduce employee-alignment concerns but does not establish superior labor practices.

No direct workforce, patient, or community metrics were provided, limiting confidence in a stronger relative social assessment versus peers.

Governance

XRAY’s leverage is elevated, and that financial structure can amplify governance scrutiny around capital allocation, covenant discipline, and board oversight versus peers.

Low stock-based compensation is a relative positive for shareholder alignment, but it is not sufficient to offset balance-sheet risk as a governance differentiator.

Moderate R&D intensity suggests ongoing investment discipline, yet the absence of filing-based board, audit, and controversy data prevents a stronger governance conclusion.

Overall governance appears average to slightly below stronger peers because capital-structure risk is more material than the limited positive signal from compensation discipline.

Overall Score

XRAY’s ESG positioning is broadly average versus peers, with modest positives in capital discipline offset by leverage-related constraints and limited direct disclosure evidence.

Score Driver: Elevated Leverage Is The Most Material Factor Limiting Relative ESG Strength Versus Peers.